Pneumabort-K+1B 1X10Ds

Composition: Killed virus vaccine containing equine herpes virus 1p and 1b (equine rhinotracheitis virus) which has been chemically inactivated with formaldehyde and combined with a specifically-prepared oil adjuvant. Pneumabort- K+1b is grown and prepared on an equine cell culture substrate.

Warnings:
• For horses only.
• Keep out of reach of children, uninformed persons and pets.
• Vaccinate healthy, non-parasitised horses only.
• When used according to instructions, it is unusual for reactions to appear other than those expected with any vaccination of horses, for example, occasional temporary local swelling. In case of anaphylactic reaction, the use of adrenalin is recommended.
• Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

Precautions:
• Empty vaccine vials and unused containers must be incinerated before being discarded.

Directions for use: Use only as directed. Shake well before and during use.
A short duration of serviceable immunity occurs after herpes virus 1 infection or vaccination. It is necessary to maintain as high a level of immunity as possible to aid in protection against upper respiratory tract infection, and spread of field strains to pregnant mares. Pregnant mares require the highest possible level of protection against infection after the fifth month of pregnancy - this should be maintained throughout the pregnancy. The vaccine is a killed virus preparation and may be administered at any time to horses or mares that may be moved from the premises, or that may be exposed to infection.

Pregnant mares: Administer 2 ml dose intramuscularly during the 5th, 7th and 9th months of pregnancy. Revaccinate annually during the 5th, 7th and 9th months if mare is pregnant. Pregnant mares that are in contact with mares that have aborted equine herpes virus 1-infected fetuses should be vaccinated. Such vaccination may provide immunity for those mares in the group which are not incubating an abortogenic infection at the time of vaccination.
Maiden and barren mares kept in barn- or pasture-contact with vaccinated pregnant mares should be vaccinated on the same schedule as the pregnant mares with which they are in contact. Mares more than 5 months pregnant at the time of arrival on a farm should be vaccinated upon arrival and at 2-month intervals until foaling.

Young horses: Administer 2 ml dose intramuscularly followed by a second 2 ml dose 3 to 4 weeks later. Revaccinate with a single 2 ml dose 6 months after the second primary dose and annually thereafter.
To ensure proper placement and retention of the vaccine, inject deep into the heavy muscles of the hindquarter. Mild exercise to promote absorption is recommended for one week after injection.

Storage instructions: Store in the dark in a refrigerator between 2-7 °C. Do not freeze.